This trial is testing whether a 7-day course of an oral, prophylactic antibiotic can reduce the incidence of periprosthetic joint infection and wound complications following primary total hip and knee arthroplasty in a high-risk patient population.
1 Primary · 1 Secondary · Reporting Duration: Within 1-year of primary hip or knee arthroplasty
Active Control
956 Total Participants · 2 Treatment Groups
Primary Treatment: Group A - antibiotic group · No Placebo Group · Phase 4
Age 18 - 99 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: